The Low Efficiency of Maternal-Neonatal Transmission of Hepatitis C Virus: How Certain Are We?

  1. Raymond S. Koff, MD
  1. University of Massachusetts Medical Center
    MetroWest Medical Center
    Framingham, MA 01701

    Excerpt

    Hepatitis C virus (HCV) is a hot topic. Because the literature is constantly expanding, keeping current with new research is no simple task for either the clinician or investigator. The "big bang" of HCV research is readily traced to the brilliant efforts and perseverance of Houghton and colleagues who, working collaboratively with Bradley, cloned the HCV genome (1). This remarkable achievement permitted a proliferation of specific assays to study HCV infection. The humoral immune response to HCV was assessed initially by radioimmunoassay, but the development of first-generation enzyme-linked immunosorbent assays (ELISAs) and recombinant immunoblot assays (RIBAs) and then second-generation assays

    This 100-word excerpt has been provided in the absence of an abstract.

    Article and Author Information

    • Requests for Reprints: Raymond S. Koff, MD, Department of Medicine, Framingham Union Hospital, 115 Lincoln St., Framingham, MA 01701.

    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med December 1, 1992 vol. 117 no. 11 967-969
    1. » Excerpt
    2. Full Text (PDF)
    3. References

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. December 15, 2009, 151 (12)
    1. Alert me to current issues